跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
M-APIXABAN
Authorized
STANDARD
M-APIXABAN
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
60a23ccded43e91f
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
60a23ccded43e91f
Drug Approval Canada Name
M-APIXABAN
Product Name
M-APIXABAN
Status
Marketed
Status Date
2022-09-21
Original Market Date
2022-09-21
Din
02529009
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF02 APIXABAN
Atc Name
b 01 af 02
Aig Number
0153051001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
APIXABAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
60a23ccded43e91f
Type
Standard
Back to Health Canada Approvals